<DOC>
	<DOC>NCT01606735</DOC>
	<brief_summary>This study will test the efficacy and safety of IBI-10090 in the treatment of ocular inflammation after ocular surgery.</brief_summary>
	<brief_title>Efficacy and Safety of IBI-10090 in Ocular Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<criteria>Patients scheduled for unilateral cataract surgery Ocular, topical, or oral corticosteroids within 7 days of Day 0</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>cataract surgery</keyword>
	<keyword>ocular inflammation</keyword>
</DOC>